| Financial Year |
March 31 2023 |
| Monetary Funds |
3,202,841,156.86 |
| Held-for-trading Financial Assets |
387,036,902.72 |
| Notes Receivable |
199,497,774.12 |
| Accounts Receivable |
5,174,324,867.49 |
| Advances to Suppliers |
363,021,939.60 |
| Other Receivables |
229,962,705.97 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
702,944,493.16 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
393,386,088.70 |
| Total Current Assets |
10,794,257,585.87 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
864,910,890.93 |
| Investment Properties |
122,297,408.18 |
| Fixed Assetes |
925,875,924.89 |
| Under-construction Projects |
165,214,904.11 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
250,309,817.28 |
| R&D expenses |
-- |
| Goodwill |
344,499,048.72 |
| Long-Term Deferred and Prepaid Expenses |
33,373,784.05 |
| Deferred Income Tax Assets |
278,173,093.40 |
| Other Non-Current Assets |
81,146,163.25 |
| Sub-Total of Non-Current Assets |
9,319,516,423.42 |
| Total Assets |
20,113,774,009.29 |
| Short-Term Loans |
1,772,155,853.09 |
| Trading Financial liabilities |
-- |
| Notes Payable |
530,131,551.51 |
| Accounts Payable |
2,434,744,963.03 |
| Accounts Received In Advance |
837,562.20 |
| Employee Compensation Payable |
91,825,092.53 |
| Taxes Payable |
142,987,798.99 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
142,723,705.08 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
80,089,762.36 |
| Other Current Liabilities |
26,276,603.97 |
| Sub-Total of Current Liabilities |
5,745,897,561.88 |
| Long-term Loans |
60,970,484.45 |
| Bonds Payable |
571,166.76 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
19,942,921.62 |
| Deferred Income Tax Liabilities |
1,551,533,451.28 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,127,235,534.52 |
| Total Liabilities |
7,873,133,096.40 |
| Paid-In Capital(Or Share Stock) |
6,754,804,205.00 |
| Capital Surplus |
1,375,391,659.41 |
| Surplus Reserve |
153,309,468.34 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
3,787,745,678.27 |
| Minority Stockholder's Interest |
38,572,935.43 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
12,202,067,977.46 |
| Owner's Equity（Stockholder's Equity） |
12,240,640,912.89 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
20,113,774,009.29 |
